## **Core Concept**
Glanzmann's thrombasthenia is a bleeding disorder characterized by the inability of platelets to aggregate. It is caused by a deficiency or dysfunction of specific platelet glycoproteins. This condition leads to impaired platelet function and increased risk of bleeding.

## **Why the Correct Answer is Right**
The correct answer, **C. Glycoprotein IIb/IIIa**, is right because Glanzmann's thrombasthenia is caused by a deficiency or qualitative defect in the glycoprotein IIb/IIIa complex on the platelet surface. This complex, also known as integrin αIIbβ3, plays a crucial role in platelet aggregation by binding to fibrinogen and von Willebrand factor, thereby facilitating platelet-platelet clumping. Without functional glycoprotein IIb/IIIa, platelets cannot aggregate properly, leading to the clinical manifestations of the disorder.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because it does not specify the correct glycoprotein involved in Glanzmann's thrombasthenia.
- **Option B:** This option is incorrect as it refers to another platelet glycoprotein, but not the one specifically implicated in Glanzmann's thrombasthenia.
- **Option D:** This option is incorrect because it refers to a different coagulation factor and not the platelet glycoprotein complex involved in Glanzmann's thrombasthenia.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl for Glanzmann's thrombasthenia is that patients typically have a normal platelet count and size but exhibit impaired platelet aggregation. A classic laboratory finding is that platelets fail to aggregate in response to adenosine diphosphate (ADP), collagen, and thrombin, but the bleeding time is usually prolonged. This condition highlights the importance of platelet glycoproteins in hemostasis.

## **Correct Answer:** . Glycoprotein IIb/IIIa